Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity
Acta Oncologica | March 12, 2013 | Volume: 52 | Issue: 3 | Pages: 498-505
10.3109/0284186x.2012.762997
| PMID 23477361